Reagents and instruments for immunology, cell biology and molecular biology.
 

TargetMol

  See all products
 
Website: 
https://www.targetmol.com
 
SARS-CoV-2 - Ruxolitinib - Therapeutic Candidates

SARS-CoV-2 - Ruxolitinib - Therapeutic Candidates

Search result : 26 product found

Refine your search :

RUOCE / IVD
  • Unconjugated 8
  • Biochemicals 18
  • Inhibitor/Antagonist/Agonist 8
APPLY FILTERS
REINITIALIZE


Cat#
Description
Cond.
Price Bef. VAT
T1829-25mg
Ruxolitinib [941678-49-5]
 25mg 
T1829-50mg
Ruxolitinib [941678-49-5]
 50mg 
T1829-500mg
Ruxolitinib [941678-49-5]
 500mg 
T1829-200mg
Ruxolitinib [941678-49-5]
 200mg 
T1829-1mL
Ruxolitinib [941678-49-5]
 1mL 
T1829-5mg
Ruxolitinib [941678-49-5]
 5mg 
T1829-10mg
Ruxolitinib [941678-49-5]
 10mg 
T1829-100mg
Ruxolitinib [941678-49-5]
 100mg 
T61988-100mg
Ruxolitinib sulfate [1092939-16-6]
 100mg 
T61988-25mg
Ruxolitinib sulfate [1092939-16-6]
 25mg 
T61988-50mg
Ruxolitinib sulfate [1092939-16-6]
 50mg 
T3043-500mg
Ruxolitinib phosphate [1092939-17-7]
 500mg 
T3043-100mg
Ruxolitinib phosphate [1092939-17-7]
 100mg 
T3043-200mg
Ruxolitinib phosphate [1092939-17-7]
 200mg 
    ‹
    ›